Molecular
Otolaryngology &
Renal Research
Laboratory
 

MORL Home

 

Clinical Diagnostics Home



Deafness Testing Requisition



Kidney Testing Requisition

Sample Requirements

 

Contact:
The University of Iowa
5270 CBRB
Iowa City, IA 52242
phone: 319-335-6623
fax:     319-353-5869

 

COCH
The Clinical Diagnostics Service of the Molecular Otolaryngology Research Laboratory is a Joint Commission-approved CLIA-accredited diagnostic laboratory that offers mutation screening of several genes.

DFNA9 (OMIM#: # 601369)
Mutations in the cochlin gene COCH are responsible for autosomal dominant nonsyndromic sensorineural hearing loss at the DNFA9 locus.  This gene maps to chromosome 14q12-q13.  Persons with hearing loss caused by a mutation in COCH can have vestibular symptoms such as vertigo or vestibular hypofunction as assessed by electronystagmography.  For this reason, some investigators have described COCH-related hearing loss as being Ménière’s-like.

Ménière’s Disease (OMIM#: #156000)
Symptoms of Ménière’s disease include hearing loss, vertigo, tinnitus and aural fullness.

COCH  (OMIM#: *603196)
COCH is a major component of the extracellular matrix of the inner ear.  The gene has 12 exons that encode a 550-amino acid protein.  At least nine different mutations in COCH have been identified in families segregating autosomal dominant nonsyndromic hearing loss with a range of clinical vestibular involvement.

MORL screening methodology
Screening for COCH is performed via DHPLC and sequencing.  Oligonucleotide primers have been designed to amplify each exon.  Amplified samples are run on the DHPLC; abnormal elution profiles are sequenced to identify specific mutations.  Exons carrying known SNPs are directly sequenced

Sensitivity
Sensitivity is greater than 99%.

Turn-around time
Turn around time is approximately 3 months.

Cost: $500

Indications for screening
This test is appropriate for any patient with autosomal dominant hearing loss at the DFNA9 locus or persons with a Ménière’s-like phenotype.

GeneTests  GeneReviews – Deafness and Hereditary Hearing Loss

References
Morrison, A.W. et al.:  Genetics (molecular biology) and Ménière’s disease.  Otolaryngol Clin North Am.  35(3): 497-516, 2002.
PubMed ID:  12486836
PubMed Search

Fransen,E. et al: High prevalence of symptoms of Ménière’s disease of three families with a mutation in the COCH gene.  Hum Mol Genet. Aug. 8(8):1425-9, 1999
PubMed ID: 1040098
PubMed Search

Verstreken, M. et al: Hereditary otovestibular dysfunction and  Ménière’s disease in a large Belgian family is caused by a missense mutation in the COCH gene.  Otol Neurotol. Nov. 22(6):874-81, 2001.
PubMed ID: 
11698812
PubMed Search

Usami, S. et al.: Mutations in the COCH gene are a frequent cause of autosomal dominant progressive cochleo-vestibular dysfunction, but not of Ménière’s disease. Eur J Hum Genet. Oct.,11(10):744-8, 2003
PubMed ID: 
14512963
PubMed Search

Sanchez, E. et al.: Absence of COCH mutations in patients with Ménière’s disease. Eur J Hum Genet. Jan.,12(1):75-8, 2004.
PubMed ID: 14704763

PubMed Search